BNZ-gamma peptide, a potential therapeutic agent in HTLV-1 associated myelopathy

por Massoud, Raya, Enose-Akahata, Yoshimi, Tagaya, Yutaka, Azimi, Nazli, Jacobson, Steven
Publicado 2014

A multi-cytokine inhibitory peptide (BNZ 132-1) that is a potential therapeutic agent for HAMTSP and other necrotizing diseases.

por Nata, Toshie, Zapata, Juan Carlos, Massoud, Raya, Jacobson, Steve, Azimi, Nazli, Tagaya, Yutaka
Publicado 2015

IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability

por Wang, T. Tiffany, Yang, Jun, Zhang, Yong, Zhang, Meili, Dubois, Sigrid, Conlon, Kevin C., Tagaya, Yutaka, Hamele, Cait E., Dighe, Shubha, Olson, Thomas L., Feith, David J., Azimi, Nazli, Waldmann, Thomas A., Loughran, Thomas P.
Publicado 2018